Categories: News

Tilray to Announce Second Quarter Fiscal 2022 Financial Results on January 10, 2022

Company to Also Host Fireside Chat at the 24th Annual ICR Conference on January 10, 2022

NEW YORK and LEAMINGTON, Ontario, Dec. 20, 2021 (GLOBE NEWSWIRE) — Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ: TLRY; TSX: TLRY) announced that the Company will release financial results for its second quarter fiscal 2022 ended November 30, 2021 before financial markets open on January 10, 2022.

Tilray executives will host a conference call and live audio webcast to discuss these results at 8:30 am Eastern Time, details of which are provided below.

Live Conference Call and Audio Webcast:

Date/Time: Monday, January 10, 2022 at 8:30 am Eastern Time.

Call-in Number: (877) 407-0792 from Canada and the U.S. or (201) 689-8263 from international locations. Please dial in at least 10 minutes prior to the start time.

A telephone replay will be available approximately two hours after the call concludes through January 26, 2022. To access the recording dial (844)-512-2921 and use the passcode 13725661.

Live Audio Webcast and Replay:

There will be a simultaneous, live webcast available on the Investors section of Tilray’s website at www.tilray.com. The webcast will also be archived.

Additionally, Tilray shareholders will be able to submit and upvote questions for the upcoming conference call to the executive team via shareholder Q&A platform Say Technologies.

To submit questions ahead of the conference call, please visit the Say platform (https://app.saytechnologies.com/tilray-2022-q2?filter=all&sort=num_shares). Tilray shareholders and brokers with Say can participate directly in their investing app or broker website. The Q&A platform for Tilray’s upcoming conference call on January 10, 2022, will remain open until 24 hours beforehand.

ICR Conference Participation

Irwin D Simon, Chairman and Chief Executive Officer, and Carl Merton, Chief Financial Officer, will also participate in a separate fireside chat discussion and hold investor meetings at the 24th Annual ICR Conference. Tilray’s fireside chat discussion will be held on Monday, January 10, 2022 at 1:30 pm Eastern Time.

The live audio webcast will be accessible in the Events & Presentation section on the Company’s Investor Relations website at https://ir.tilray.com/events-and-presentations/events. An archived replay of the webcast will also be available shortly after the live event has concluded.

About Tilray

Tilray Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.

For more information about Tilray, Inc., visit: http://www.Tilray.com 

Contacts
For media inquiries, please contact:
Berrin Noorata
news@tilray.com 

For investor inquiries, please contact:
Raphael Gross 203-682-8253
Raphael.Gross@icrinc.com 

Staff

Recent Posts

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

2 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

5 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

5 hours ago

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and…

5 hours ago

A Christmas Message to the DEA’s Diversion Anti Marijuana Cabal

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally…

8 hours ago

Kanazawa University research: High-speed AFM imaging reveals how brain enzyme forms dodecameric ring structure

KANAZAWA, Japan, Dec. 26, 2025 /PRNewswire/ -- Scientists at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa…

14 hours ago